Company intelligence / Profile preview
Harbin Medical University Pharmaceutical
Harbin, Heilongjiang Sheng, China
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
Harbin Medical University Pharmaceutical Co Ltd. has developed at least three approved drugs, including a traditional Chinese medicine for the common cold and arsenious acid for hematologic cancer, as well as a peptide drug conjugate in Phase 2 trials for solid and colonic tumors.[3]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeHerbal medicinePeptide drug conjugate
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Harbin Medical University Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Harbin Medical University Pharmaceutical.